Literature DB >> 31248335

Plasma Peptidylarginine Deiminase IV Promotes VWF-Platelet String Formation and Accelerates Thrombosis After Vessel Injury.

Nicoletta Sorvillo1,2, Daniella M Mizurini1,2, Carmen Coxon3, Kimberly Martinod1,2, Ronak Tilvawala4, Deya Cherpokova1,2, Ari J Salinger4, Robert J Seward5, Caleb Staudinger1, Eranthie Weerapana6, Nathan I Shapiro7, Catherine E Costello5, Paul R Thompson4, Denisa D Wagner1,8,2.   

Abstract

RATIONALE: PAD4 (peptidylarginine deiminase type IV), an enzyme essential for neutrophil extracellular trap formation (NETosis), is released together with neutrophil extracellular traps into the extracellular milieu. It citrullinates histones and holds the potential to citrullinate other protein targets. While NETosis is implicated in thrombosis, the impact of the released PAD4 is unknown.
OBJECTIVE: This study tests the hypothesis that extracellular PAD4, released during inflammatory responses, citrullinates plasma proteins, thus affecting thrombus formation. METHODS AND
RESULTS: Here, we show that injection of r-huPAD4 in vivo induces the formation of VWF (von Willebrand factor)-platelet strings in mesenteric venules and that this is dependent on PAD4 enzymatic activity. VWF-platelet strings are naturally cleaved by ADAMTS13 (a disintegrin and metalloproteinase with thrombospondin type-1 motif-13). We detected a reduction of endogenous ADAMTS13 activity in the plasma of wild-type mice injected with r-huPAD4. Using mass spectrometry and in vitro studies, we found that r-huPAD4 citrullinates ADAMTS13 on specific arginine residues and that this modification dramatically inhibits ADAMTS13 enzymatic activity. Elevated citrullination of ADAMTS13 was observed in plasma samples of patients with sepsis or noninfected patients who were elderly (eg, age >65 years) and had underlying comorbidities (eg, diabetes mellitus and hypertension) as compared with healthy donors. This shows that ADAMTS13 is citrullinated in vivo. VWF-platelet strings that form on venules of Adamts13-/- mice were immediately cleared after injection of r-huADAMTS13, while they persisted in vessels of mice injected with citrullinated r-huADAMTS13. Next, we assessed the effect of extracellular PAD4 on platelet-plug formation after ferric chloride-induced injury of mesenteric venules. Administration of r-huPAD4 decreased time to vessel occlusion and significantly reduced thrombus embolization.
CONCLUSIONS: Our data indicate that PAD4 in circulation reduces VWF-platelet string clearance and accelerates the formation of a stable platelet plug after vessel injury. We propose that this effect is, at least in part, due to ADAMTS13 inhibition.

Entities:  

Keywords:  citrullination; histones; peptidylarginine deiminase IV; thrombosis; von Willebrand factor

Year:  2019        PMID: 31248335      PMCID: PMC6697196          DOI: 10.1161/CIRCRESAHA.118.314571

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  67 in total

1.  von Willebrand factor and factor VIII are independently required to form stable occlusive thrombi in injured veins.

Authors:  Anil K Chauhan; Janka Kisucka; Colin B Lamb; Wolfgang Bergmeier; Denisa D Wagner
Journal:  Blood       Date:  2006-11-21       Impact factor: 22.113

2.  Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure.

Authors:  Tomoko Ono; Jun Mimuro; Seiji Madoiwa; Kenji Soejima; Yuji Kashiwakura; Akira Ishiwata; Katsuhiro Takano; Tsukasa Ohmori; Yoichi Sakata
Journal:  Blood       Date:  2005-09-27       Impact factor: 22.113

3.  FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay.

Authors:  Koichi Kokame; Yuko Nobe; Yoshihiro Kokubo; Akira Okayama; Toshiyuki Miyata
Journal:  Br J Haematol       Date:  2005-04       Impact factor: 6.998

4.  Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization.

Authors:  Yuan Luo; Kyouhei Arita; Monica Bhatia; Bryan Knuckley; Young-Ho Lee; Michael R Stallcup; Mamoru Sato; Paul R Thompson
Journal:  Biochemistry       Date:  2006-10-03       Impact factor: 3.162

5.  Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease.

Authors:  Akihito Ishigami; Takako Ohsawa; Masaharu Hiratsuka; Hiromi Taguchi; Saori Kobayashi; Yuko Saito; Shigeo Murayama; Hiroaki Asaga; Tosifusa Toda; Narimichi Kimura; Naoki Maruyama
Journal:  J Neurosci Res       Date:  2005-04-01       Impact factor: 4.164

6.  ABAP: antibody-based assay for peptidylarginine deiminase activity.

Authors:  Albert J W Zendman; Reinout Raijmakers; Suzanne Nijenhuis; Erik R Vossenaar; Marloes van den Tillaart; Renato G S Chirivi; Jos M H Raats; Walther J van Venrooij; Jan W Drijfhout; Ger J M Pruijn
Journal:  Anal Biochem       Date:  2007-07-21       Impact factor: 3.365

7.  Proteolytic inactivation of ADAMTS13 by thrombin and plasmin.

Authors:  James T B Crawley; Jonathan K Lam; James B Rance; Luigina R Mollica; James S O'Donnell; David A Lane
Journal:  Blood       Date:  2004-09-23       Impact factor: 22.113

8.  Basal secretion of von Willebrand factor from human endothelial cells.

Authors:  Jonathan P Giblin; Lindsay J Hewlett; Matthew J Hannah
Journal:  Blood       Date:  2008-03-14       Impact factor: 22.113

9.  ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions.

Authors:  Jing-fei Dong; Joel L Moake; Leticia Nolasco; Aubrey Bernardo; Wendy Arceneaux; Corie N Shrimpton; Alicia J Schade; Larry V McIntire; Kazuo Fujikawa; José A López
Journal:  Blood       Date:  2002-07-25       Impact factor: 22.113

10.  Systemic antithrombotic effects of ADAMTS13.

Authors:  Anil K Chauhan; David G Motto; Colin B Lamb; Wolfgang Bergmeier; Michael Dockal; Barbara Plaimauer; Friedrich Scheiflinger; David Ginsburg; Denisa D Wagner
Journal:  J Exp Med       Date:  2006-03-13       Impact factor: 14.307

View more
  23 in total

Review 1.  Neutrophil Extracellular Traps Participate in Cardiovascular Diseases: Recent Experimental and Clinical Insights.

Authors:  Yvonne Döring; Peter Libby; Oliver Soehnlein
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

2.  Recombinant human ADAMTS13 treatment and anti-NET strategies enhance skin allograft survival in mice.

Authors:  Siu Ling Wong; Jeremy Goverman; Caleb Staudinger; Denisa D Wagner
Journal:  Am J Transplant       Date:  2019-12-12       Impact factor: 8.086

Review 3.  Thromboinflammation: From Atherosclerosis to COVID-19.

Authors:  Denisa D Wagner; Lukas A Heger
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-07-08       Impact factor: 10.514

Review 4.  Composition and Organization of Acute Ischemic Stroke Thrombus: A Wealth of Information for Future Thrombolytic Strategies.

Authors:  Jean-Philippe Desilles; Lucas Di Meglio; Francois Delvoye; Benjamin Maïer; Michel Piotin; Benoît Ho-Tin-Noé; Mikael Mazighi
Journal:  Front Neurol       Date:  2022-07-06       Impact factor: 4.086

Review 5.  Neutrophils and Platelets: Immune Soldiers Fighting Together in Stroke Pathophysiology.

Authors:  Junaid Ansari; Felicity N E Gavins
Journal:  Biomedicines       Date:  2021-12-19

Review 6.  The Role of Neutrophils and Neutrophil Extracellular Traps in Vascular Damage in Systemic Lupus Erythematosus.

Authors:  Liam J O'Neil; Mariana J Kaplan; Carmelo Carmona-Rivera
Journal:  J Clin Med       Date:  2019-08-28       Impact factor: 4.241

Review 7.  Neutrophils as a Novel Target of Modified Low-Density Lipoproteins and an Accelerator of Cardiovascular Diseases.

Authors:  Takashi Obama; Hiroyuki Itabe
Journal:  Int J Mol Sci       Date:  2020-11-05       Impact factor: 5.923

Review 8.  PAD4 takes charge during neutrophil activation: Impact of PAD4 mediated NET formation on immune-mediated disease.

Authors:  Xiaosong Liu; Tom Arfman; Kanin Wichapong; Chris P M Reutelingsperger; Jan Voorberg; Gerry A F Nicolaes
Journal:  J Thromb Haemost       Date:  2021-05-12       Impact factor: 5.824

Review 9.  Role of HMGB1 in the Interplay between NETosis and Thrombosis in Ischemic Stroke: A Review.

Authors:  Seung-Woo Kim; Ja-Kyeong Lee
Journal:  Cells       Date:  2020-07-28       Impact factor: 6.600

10.  The role of SERPIN citrullination in thrombosis.

Authors:  Ronak Tilvawala; Venkatesh V Nemmara; Archie C Reyes; Nicoletta Sorvillo; Ari J Salinger; Deya Cherpokova; Saeko Fukui; Sarah Gutch; Denisa Wagner; Paul R Thompson
Journal:  Cell Chem Biol       Date:  2021-08-04       Impact factor: 8.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.